Pharma-Bio Serv, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending July 31, 2024 was 23M shares, a 0.1% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 23M shares, a 0.15% decline from 2022.
  • Pharma-Bio Serv, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 23M shares, a 0.56% decline from 2021.
  • Pharma-Bio Serv, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 23.2M shares, a 0.53% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 23M -23K -0.1% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 23M -47.8K -0.21% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 23M +28.6K +0.13% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 23M -34K -0.15% Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 23M +13.6K +0.06% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 23M +29.3K +0.13% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 23M -76.2K -0.33% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 23M -130K -0.56% Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 23M -204K -0.88% May 1, 2022 Jul 31, 2022 10-Q 2023-09-14
Q1 2022 23M -222K -0.96% Jan 31, 2022 Apr 30, 2022 10-Q 2022-06-14
Q4 2021 23M -138K -0.6% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 23.2M +122K +0.53% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 23.2M +142K +0.62% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 23.2M +180K +0.78% Jan 31, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 23.2M +154K +0.67% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 23M -73.8K -0.32% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 23M -5.6K -0.02% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 23M -39.7K -0.17% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 23M -100K -0.44% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-17
Q3 2019 23.1M +17.6K +0.08% Aug 1, 2019 Oct 31, 2019 10-K 2021-02-01
Q2 2019 23M -36.4K -0.16% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 23.1M +6.39K +0.03% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q4 2018 23.1M +53.7K +0.23% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 23.1M -3.12K -0.01% Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 23.1M -27.3K -0.12% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 23.1M -48K -0.21% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 23.1M -23.3K -0.1% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 23.1M -86.6K -0.37% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-29
Q2 2017 23.1M -27.8K -0.12% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 23.1M -134K -0.58% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
Q4 2016 23.1M -170K -0.73% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 23.2M -214K -0.92% Aug 1, 2016 Oct 31, 2016 10-K 2018-01-29
Q2 2016 23.1M -225K -0.96% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 23.2M -184K -0.78% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 23.3M -206K -0.88% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 23.4M -294K -1.24% Aug 1, 2015 Oct 31, 2015 10-K 2017-01-31
Q2 2015 23.4M -255K -1.08% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 23.4M -360K -1.51% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-14
Q4 2014 23.5M -261K -1.1% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 23.7M +33.8K +0.14% Aug 1, 2014 Oct 31, 2014 10-K 2016-01-29
Q2 2014 23.6M +271K +1.16% May 1, 2014 Jul 31, 2014 10-Q 2015-09-14
Q1 2014 23.8M +422K +1.81% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 23.7M +907K +3.98% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 23.7M +721K +3.14% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-29
Q2 2013 23.3M +358K +1.56% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 23.4M +537K +2.35% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-16
Q4 2012 22.8M +68.9K +0.3% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 22.9M +386K +1.71% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 23M +465K +2.07% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 22.8M +346K +1.54% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 22.7M +275K +1.23% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 22.6M Aug 1, 2011 Oct 31, 2011 10-K 2013-01-29
Q2 2011 22.5M +72.6K +0.32% May 1, 2011 Jul 31, 2011 10-Q 2012-09-14
Q1 2011 22.5M Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 22.5M Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q2 2010 22.4M May 1, 2010 Jul 31, 2010 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.